Emerging Opportunities Through Platform Drug Development
Produced by BryceTech
A typical therapeutic drug takes about 15 years and $1 to 2 billion to develop, with clinical trials and FDA review driving most of that schedule. This infographic from BryceTech’s Biosecurity & Emerging Threats Division shows how platform drug development compresses that timeline, a critical advantage when responding to emerging health threats.
Key insights:
- Traditional development: ~15 years, $1 to 2 billion, thousands of trial patients
- Platform development: ~2 years, $300 to 800 million, built on proven safety data
- Reformulation in weeks: Platform drugs can be adapted to new indications in as little as weeks
- Built for resilience: Standardized, modular, and scalable, with drug substance produced on demand on-shore
Platform technologies give the United States a faster, more resilient path to new therapies, complementing traditional development when speed matters most.
